Treatment of Trichinellosis During Pregnancy and in Children

Trichinellosis in pregnant women and pediatric patients is a clinical situation where the standard anthelmintic selection must be specifically considered for the patient population involved.

This protocol is for trichinellosis occurring in children or in pregnant women — populations for which a distinct anthelmintic approach has been proposed.

An anthelmintic agent has been proposed for use in these populations. The complete therapeutic approach — including the full regimen and its application — is available in the structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1128/cmr.00026-08

Pyrantel (CombantrinR, Pfizer) has been proposed for children and pregnant women (Kociecka, 1988), and flubendazole has been used in some countries.

View source ↗